Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v21-EN Version v1-EN
Language English English
Date Updated 2023-07-19 2022-11-25
Drug Identification Number 02525178 02525178
Brand name TARO-CALCIPOTRIOL / BETAMETHASONE GEL TARO-CALCIPOTRIOL / BETAMETHASONE GEL
Common or Proper name CB GEL CB GEL
Company Name TARO PHARMACEUTICALS INC TARO PHARMACEUTICALS INC
Ingredients BETAMETHASONE CALCIPOTRIOL BETAMETHASONE CALCIPOTRIOL
Strength(s) 0.5MG 50MCG 0.5MG 50MCG
Dosage form(s) GEL GEL
Route of administration TOPICAL TOPICAL
Packaging size 60 60
ATC code D05AX D05AX
ATC description ANTIPSORIATICS FOR TOPICAL USE ANTIPSORIATICS FOR TOPICAL USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-11-14 2022-11-14
Estimated end date 2023-08-18 2022-12-30
Actual end date 2023-07-18
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments